• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    125.07 Down 3.87(3.00%) Apr 17, 4:00PM EDT
    |After Hours : 125.01 Down 0.06 (0.05%) Apr 17, 5:47PM EDT
    Add to Portfolio
    Prev Close:128.94
    Open:127.52
    Bid:121.98 x 100
    Ask:126.12 x 500
    1y Target Est:133.63
    Beta:-0.64
    Next Earnings Date:29-Apr-15VRTX Earnings announcement
    Day's Range:124.46 - 128.90
    52wk Range:62.41 - 136.33
    Volume:1,579,115
    Avg Vol (3m):1,664,250
    Market Cap:30.28B
    P/E (ttm):N/A
    EPS (ttm):-3.14
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VRTXDown 3.00%30.28B
    BMYUp 2.62%108.62B
    MRKDown 1.66%161.44B
    PTCTDown 0.35%2.33B

    Key Statistics

    Forward P/E (1 yr):33.99
    P/S (ttm):53.78
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.63
    Quarterly EPS Est (Mar-15) :-0.75
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-2.65

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback